Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant

Outcome in Renal AL Amyloidosis After Chemotherapy

(2011) Jennifer H. Pinney et al.   JOURNAL OF CLINICAL ONCOLOGY

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

(2010) Karl Bodin et al.   NATURE

Transthyretin-related amyloidoses and the heart: a clinical overview

(2010) Claudio Rapezzi et al.   Nature Reviews Cardiology

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

(2008) Maarit Tanskanen et al.   ANNALS OF MEDICINE

Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

(2008) Yoshiki Sekijima et al.   CURRENT PHARMACEUTICAL DESIGN

Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

(2008) O. B. Suhr et al.   JOURNAL OF INTERNAL MEDICINE